Paradigm Financial Partners, LLC Bristol Myers Squibb CO Transaction History
Paradigm Financial Partners, LLC
- $947 Million
- Q4 2025
A detailed history of Paradigm Financial Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 10,776 shares of BMY stock, worth $504,424. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,776
Previous 8,564
25.83%
Holding current value
$504,424
Previous $386,000
30.57%
% of portfolio
0.05%
Previous 0.04%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,732Shares Held
1.58BCall Options Held
28.7MPut Options Held
28.6M-
Vanguard Group Inc Valley Forge, PA199MShares$9.3 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...